HealthLynked Corp.
HLYK
$3.50
$0.030.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -31.36% | -27.42% | -36.82% | -44.24% | -47.45% |
| Total Other Revenue | -30.15% | -95.29% | -15.01% | -31.41% | -44.92% |
| Total Revenue | -31.35% | -28.51% | -36.61% | -44.11% | -47.43% |
| Cost of Revenue | -48.92% | -39.54% | -36.05% | -36.56% | -38.01% |
| Gross Profit | 8.75% | -4.82% | -37.59% | -55.53% | -60.96% |
| SG&A Expenses | -33.02% | -37.61% | -36.30% | -24.16% | -16.13% |
| Depreciation & Amortization | -63.98% | -69.72% | -52.14% | -35.98% | -19.65% |
| Other Operating Expenses | -37.49% | -32.14% | -31.00% | -32.73% | -29.40% |
| Total Operating Expenses | -40.05% | -38.46% | -35.74% | -30.76% | -27.05% |
| Operating Income | 46.66% | 46.10% | 34.89% | 13.97% | -3.39% |
| Income Before Tax | 46.50% | 38.03% | -13.26% | -51.54% | -69.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.50% | 38.03% | -13.26% | -51.54% | -69.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.50% | 38.03% | -12.91% | -50.43% | -505.69% |
| EBIT | 46.66% | 46.10% | 34.89% | 13.97% | -3.39% |
| EBITDA | 46.13% | 45.60% | 33.88% | 17.13% | -0.70% |
| EPS Basic | 46.84% | 38.79% | -10.86% | -44.26% | -495.98% |
| Normalized Basic EPS | 41.64% | 27.88% | 12.98% | -11.62% | -17.39% |
| EPS Diluted | 55.87% | 49.03% | 13.60% | -76.36% | -621.13% |
| Normalized Diluted EPS | 41.64% | 27.88% | 12.98% | -11.62% | -17.39% |
| Average Basic Shares Outstanding | 0.73% | 1.42% | 2.82% | 4.91% | 7.10% |
| Average Diluted Shares Outstanding | 0.73% | 1.42% | 2.82% | 4.91% | 7.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |